Alsup Mulls $113M Atty Fees In $454M Glumetza Antitrust Deal
By Hannah Albarazi · January 20, 2022, 5:57 PM EST
U.S. District Judge William H. Alsup said on Thursday he will grant final approval to $454 million in settlements resolving direct Glumetza buyers' class claims that drugmakers plotted to delay the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login